Watching too much TV is associated with increased risk of coronary heart disease regardless of an individual’s genetic makeup, say a team of scientists at the

The 57-year-old patient who survived two months after undergoing a landmark pig heart transplant died of a pig virus, his transplant surgeon announced last month. In January, David Bennett, a handyman who suffered from heart failure, underwent a highly experimental surgery at the University of Maryland medical center in which doctors transplanted a genetically modified pig’s heart into him.

In a study of 20 participants, those that slept with a light had worse blood sugar control the next morning compared to those who snoozed in total darkness

Asthma or allergies may be linked to future high blood pressure and heart disease, according to a new study.

Scientists have developed a blood test that can predict whether someone is at high risk of a heart attack, stroke, heart failure or dying from one of these conditions within the next four years. The test, which relies of measurements of proteins in the blood, has roughly twice the accuracy of existing risk scores. It could enable doctors to determine whether patients’ existing medications are working or whether they need additional drugs to reduce their risk.

Using advanced 3D printing techniques, Mark Skylar-Scott and his team of Stanford bioengineers want to transform a paste made of living cells into hearts and other organs.

A 57-year-old man with terminal heart disease who made history as the first person to receive a genetically modified pig’s heart died on Tuesday at the University of Maryland Medical Center (UMMC), the hospital said.

The man died two months after operation, says the hospital that carried out the world-first surgery.

We aimed to investigate the association of serum pentadecanoic acid (15:0), a biomarker of dairy fat intake, with incident cardiovascular disease (CVD) and all-cause mortality in a Swedish cohort study. We also systematically reviewed studies of the association ...

A potentially game-changing "bionic" pacemaker capable of restoring the human heart's naturally irregular beat is set to undergo trials involving heart patients in New Zealand this year. We may be on the medical precipice of turning back time, or actually reversing the heart rhythm effects of cardiac events.

Device offers insights into artificial muscular pumps, a step toward building an artificial heart

A revolutionary pacemaker that re-establishes the heart's naturally irregular beat is set to be trialled in New Zealand heart patients this year, following successful animal trials. "Currently, all pacemakers pace the heart metronomically, which means a very steady, even pace. But when you record heart rate in a healthy individual, you see it is constantly on the move," says Professor Julian Paton, a lead researcher and director of Manaaki Manawa, the Centre for Heart Research at the University of Auckland.

A revolutionary pacemaker that re-establishes the heart’s naturally irregular beat is set to be trialled in New Zealand heart patients this year.

A U.S. man with terminal heart disease was implanted with a genetically modified pig heart in a first-of-its-kind surgery, and three days later the patient is doing well, his doctors reported on Monday.

A 57-year-old Maryland man is doing well three days after receiving a genetically modified pig heart in a first-of-its-kind transplant surgery, University of Maryland Medicine said in a news release Monday.

A Maryland man has lived for three days with a pig heart beating inside his chest. The surgery, at the University of Maryland Medical Center, marks the first time a gene-edited pig has been used as an organ donor.

In a historic procedure surgeons in the US have, for the first time, transplanted a genetically modified pig heart into a living human. The patient is currently still alive, has not rejected the pig organ and is being carefully monitored at the University of Maryland Medical Center.

A doctor passing by saw the man and called for help.

Scientists at the Washington University School of Medicine have made an intriguing discovery that could see radiation therapy become a less invasive treatment for heart arrhythmia. The technique seems to activate the heart cells to revert to a younger state and repair the tissue.

A UCL-led research team has identified a new gene as a cause of hypertrophic cardiomyopathy, an inherited heart condition affecting one in 500 people.